The approach advances next-generation minimally invasive BCI hardware.11
Deep research (2026-07-20)
Source note: the exact bioRxiv URL could not be retrieved; findings below use the matching peer-reviewed paper — Liang J, Wang X, Chen Z, et al. “Silk-enabled conformal intraventricular interfaces for minimally invasive neural recordings,” Nat Commun. 2025 Oct 23;16(1):9366.23
Authors/institutions: Jizhi Liang & Xiner Wang (co-first), Zhaohan Chen, Xiaoling Wei, Liuyang Sun, Keyin Liu, Zhifeng Shi (Huashan Hospital, Fudan University Neurosurgery), Tiger H. Tao and Zhitao Zhou (co-corresponding), 2020 X-Lab & State Key Lab of Transducer Technology, SIMIT, Chinese Academy of Sciences, and Neuroxess Co., Ltd.; funded by CAS (Y2023070) and Shanghai STC (22QA1410900).3
Device: a flexible, conformal intraventricular interface (IVI) combining a deformable microelectrode array bonded to a silk-fibroin scaffold, designed to self-unfold once inside cerebrospinal fluid.3
Delivery approach: minimally invasive implantation into the lateral ventricles using commonly available clinical catheters — no open craniotomy or endovascular stent-retrieval procedure required, distinguishing it from Stentrode’s venous-sinus route and from subdural ECoG grids that require craniotomy.3
Mechanism: the silk scaffold enables the electrode array to self-unfold and conformally attach to periventricular (subcortical) surfaces within the CSF-filled ventricle, exploiting silk’s dissolution/softening in aqueous physiological environments.3
Signal quality: the microelectrodes use an in-plane shielding architecture the authors state enables high-quality signals from periventricular structures; specific SNR (dB) or impedance (kΩ) values were not reported in the retrieved abstract — not reported.3
Animal model: validated in vivo in parkinsonian ewes (sheep) — a large-animal model with ventricular/brain size relevant to humans; the exact number of animals was not stated — not reported.3
Chronic performance: the IVI achieved stable, biocompatible recordings for four weeks in vivo and detected deep-brain electrophysiological abnormalities associated with the parkinsonian model.3
Translational/BCI implication: establishes a new “third route” for deep/subcortical interfacing — alongside subdural and stereotactic penetrating electrodes — potentially enabling chronic monitoring of deep circuits (basal-ganglia-adjacent, periventricular) implicated in Parkinson’s and other movement/psychiatric disorders without penetrating brain parenchyma.3
Positioning: contrasts with Synchron’s Stentrode (endovascular, delivered via jugular/venous sinus to sit against cortex from inside a vessel) and standard subdural grids (craniotomy) by using the ventricular CSF space plus a soft self-conforming material as the minimally invasive route, enabling circuit-level study of periventricular–cortical interactions during chronic monitoring.3
Related work
Oxley TJ, et al. “Minimally invasive endovascular stent-electrode array for high-fidelity, chronic recordings of cortical neural activity” (Stentrode), Nature Biotechnology, 2016.
Silk bioresorbable/flexible neural-electrode literature from the Tao lab (SIMIT), including prior silk-based cortical electrode arrays.